Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca’s: study – MarketWatch

A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer and Moderna vaccines as they are for the AstraZeneca vaccine that was produced with the university’s help. According to the study, 4 in 1 million people experience cerebral venous thrombosis after getting the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 — 39 in a million patients — than it is for those for get vaccinated. AstraZeneca’s vaccine use has been halted or limited in many countries on blood clot concerns.


Majority of new COVID-19 hospitalizations in New York are people who stayed at home – MarketWatch

The vast majority of New Yorkers still walking into hospitals with COVID-19 have been sheltering at home and avoiding mass transit. Very few were even traveling on foot or in their own cars on a daily basis, according to a survey of new patients from over 100 hospitals across the state over a three-day span. Of those surveyed, 66% were at home before entering the hospital.

  • Two in three people coming into hospitals with the virus were simply at home, Cuomo said.
  • Of the 1,270 new patients surveyed, 18% were from nursing homes across New York state
  • 4% were from assisted living facilities
  • 2% were homeless
  • Less than 1% were from prisons or jails
  • Only 4% of those newly infected said they took public transportation on a daily basis.